Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.
By R. Hundal, K. Petersen, Adam Mayerson, P. Randhawa, Silvio E. Inzucchi, S. Shoelson, Gerald I. Shulman. Journal of Clinical Investigation, 2002
708 citations recorded by the source corpus.
Subfields: Epidemiology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/0889cc0baca84335c6de858c464a8cbe69a4fdad
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- Jerrold M. Olefsky
- Herbert Tilg
- Haiming Cao
- G. Hotamışlıgil
- A. Moschen
- Gerald I. Shulman
- Jongsoon Lee
- Mitchell A. Lazar
In Molecular Biology
- K. Petersen
- Gerald I. Shulman
- G. Hotamışlıgil
- G. Hotamisligil
- K. Wellen
- Jerrold M. Olefsky
- Mitchell A. Lazar
- M. Qatanani
Citations in the corpus
- Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB (2005, methodology): “We isolated IKK complexes from mouse liver lysates using anti-IKK-γ antibodies (PharMingen) coupled to protein A-Sepharose, and conducted in vitro kinase assays at 30 °C by adding [γ-32P]ATP and 2 μg of GST-IκBα (1-54)12.”
- Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. (2014, background): “Salicylate and salsalate Sodium salicylate and aspirin have demonstrated beneficial effects in the treatment of T2DM by improving glycaemic control through inhibition of NF-κB activity [72, 73].”
- Mechanisms of obesity-associated insulin resistance: many choices on the menu. (2007, background): “Moreover, inhibition of IKK in human diabetics by high-dose aspirin treatment also improves insulin signaling (Yin et al. 1998; Hundal et al. 2002).”
- Inflammatory Mechanisms in the Regulation of Insulin Resistance (2008, background): “Whereas these effects might be mainly attributed to its effect on NF-κB inhibition (74), recent studies have also demonstrated that that high-dose aspirin (up to 7 g/day) improves glucose tolerance and triglyceride levels (120).”
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. (2012, positive): “Double-stranded RNA-dependent protein kinase (PKR) and I κ B kinase (IKK) are two stress-sensitive kinases that mediate serine phosphorylation of IRS-1 and are critical regulators of peripheral insulin resistance (36–39).”
- The cellular and signaling networks linking the immune system and metabolism in disease (2012, background): “In humans, salicylate treatment enhanced insulin sensitivity in a small group of subjects with diabete”
- Adipokines: the missing link between insulin resistance and obesity. (2008, background): “[112] Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, et al.”